ATOMIC ENERGY COUNCIL;INSTITUTE OF NUCLEAR ENERGY RESEARCH
发明人:
KUO, WAN I,郭宛宜,CHENG, KAI HUNG,郑凯鸿,鄭凱鴻,HUANG, YI SHU,黄益书,黃益書,LO, SHENG NAN,罗盛男,羅盛男,CHANG, YA JEN,张雅珍,張雅珍,WU, TSUNG TSE,吴宗泽,吳宗澤,HSU, WEI CHUAN,徐维荃,徐維荃,LI, MING HSIN,李铭忻,李銘忻,CHANG, CHIH HSIEN,张志贤,張志
申请号：
TW105113746
公开号：
TW201808329A
申请日:
2016.05.03
申请国别(地区):
TW
年份:
2018
代理人:
摘要：
Disclosed herein is an radioimmune complex which has a epidermal growth factor receptor-targeted antibody and rhenium labeled thereof. The epidermal growth factor receptor-targeted antibody is cetuximab or panitumumab.本發明揭示一種放射免疫複合體，其包含一表皮生長因子受體之標靶抗體和標誌於所述抗體上的錸放射性核種。所述標靶抗體是西妥昔單株抗體或帕尼單株抗體。
